(Q28251474)

English

Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma

scientific article

In more languages

Statements

scholarly article

0 references

Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma (English)

0 references

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Robert A Winn

1

0 references

Michelle Van Scoyk

2

0 references

Mandy Hammond

3

0 references

Karen Rodriguez

4

0 references

Joseph T Crossno

5

0 references

Lynn E Heasley

6

0 references

Raphael A Nemenoff

7

0 references

language of work or name

0 references

publication date

15 September 2006

0 references

Journal of Biological Chemistry

0 references

281

0 references

26943-50

0 references

37

0 references

LDL-receptor-related proteins in Wnt signal transduction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize beta-catenin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

The significance of the Wnt pathway in the pathology of human cancers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Wnt signaling in lung cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Peroxisome-proliferator-activated receptors and cancers: complex stories

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Epithelial-mesenchymal transitions in development and pathologies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Altered HOX and WNT7A expression in human lung cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Role of nuclear receptors in lung tumourigenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Galpha q and Galpha 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras AND Rho-independent pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Kinase signaling cascades that modulate peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Interdomain communication regulating ligand binding by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604145200

21 January 2018

Identifiers

10.1074/JBC.M604145200

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28251474&oldid=2005325052"